Immunogenic cell death in cancer therapy: Present and emerging inducers-Reference-Cited by-同舟云学术

Immunogenic cell death in cancer therapy: Present and emerging inducers

Published:2019-06-18 Issue:8 Volume:23 Page:4854-4865
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Zhou Jingyi¹²,Wang Gangyang¹^ORCID,Chen Yinze²,Wang Hongxia³,Hua Yingqi¹,Cai Zhengdong¹

Affiliation:

1. Department of Orthopaedics Shanghai Bone Tumor Institute, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China

2. Fourth Clinical College Xinxiang Medical University Henan China

3. Department of Oncology Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Shanghai PR China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14356

Reference86 articles.

1. Immune surveillance of tumors

2. The concept of immune surveillance against tumors: The first theories

3. NK cells and cancer immunosurveillance

4. Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go

5. Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment

Cited by 512 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing nanomaterials for copper-induced cell death;Biomaterials;2025-02

2. Advances in therapeutic cancer vaccines: Harnessing immune adjuvants for enhanced efficacy and future perspectives;Computational and Structural Biotechnology Journal;2024-12

3. ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy;Life Sciences;2024-11

4. Visualized photodynamic nanomaterials activating tumor-associated immune landscape as a next-generation anticancer strategy;Coordination Chemistry Reviews;2024-10

5. Predicting resistance and pseudoprogression: are minimalistic immunoediting mathematical models capable of forecasting checkpoint inhibitor treatment outcomes in lung cancer?;Mathematical Biosciences;2024-10